NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $596,883 | +84.2% | 5,915 | +65.6% | 0.17% | +29.2% |
| Q4 2022 | $324,052 | -54.0% | 3,572 | -61.5% | 0.13% | -52.6% |
| Q3 2022 | $704,000 | +12.8% | 9,266 | +25.5% | 0.27% | -12.2% |
| Q2 2022 | $624,000 | +74.3% | 7,386 | +88.4% | 0.31% | -4.3% |
| Q2 2021 | $358,000 | +72.1% | 3,920 | +64.4% | 0.33% | +18.5% |
| Q2 2020 | $208,000 | -55.0% | 2,385 | -55.1% | 0.28% | -34.7% |
| Q3 2019 | $462,000 | -13.5% | 5,316 | -14.5% | 0.42% | +48.8% |
| Q4 2018 | $534,000 | -6.0% | 6,219 | -5.7% | 0.28% | +14.1% |
| Q3 2018 | $568,000 | +50.3% | 6,594 | +49.9% | 0.25% | +131.8% |
| Q3 2017 | $378,000 | -3.6% | 4,400 | -6.4% | 0.11% | -21.3% |
| Q2 2017 | $392,000 | +30.7% | 4,700 | +23.7% | 0.14% | -23.2% |
| Q3 2016 | $300,000 | -40.4% | 3,800 | -37.7% | 0.18% | -27.5% |
| Q2 2016 | $503,000 | +73.4% | 6,100 | +52.5% | 0.24% | +25.8% |
| Q1 2016 | $290,000 | – | 4,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |